cell-therapy

Documents about cell-therapy

• Antibiotic therapy reduces nitrosative stress and programmed cell death in the rabbit foetal lung#430267HAL (France)
• Allogeneic Stem Cell Transplantation Followed By Targeted Immune Therapy In Average Risk Leukemia#444861ClinicalTrials.gov
• Targeted delivery of mRNA to immune cells for#455650PubMed
• Intraperitoneal rescue stem cell therapy in experimental NEC mitigates intestinal, pulmonary, and neuroinflammatory injury in mice.#615840NCBI PubMed Central
• Allogeneic Stem Cell Transplantation in Chronic Myeloid Leukemia Failing TKIs Therapy#806401ClinicalTrials.gov
• Child's Adipose Cells: Capacity of Tissue Regeneration#812274ClinicalTrials.gov
• A Phase 2 Clinical Study of Combination Therapy With ABSK043 and Glecirasib#832239ClinicalTrials.gov
• Dissecting Tumour MicroenvirOnment in Solid Paediatric Tumour to Improve Adoptive Cell Therapy#837451ClinicalTrials.gov
• Perceptions of Cell and Gene Therapies (CGT) for the Treatment of Cancer#851391ClinicalTrials.gov
• Gated Intensity Modulated Radiation Therapy and Concurrent Chemotherapy for Inoperable NSCLC#852648ClinicalTrials.gov
• Nk Cell Therapy for Recurrent Glioblastoma Multiform Patients#857728ClinicalTrials.gov
• Stem Cell Therapy for Type 1 Diabetes Mellitus#861026ClinicalTrials.gov
• Blood Endothelial-Cell Extracellular Vesicles as Potential Biomarkers for the Selection of Plasma in COVID-19 Convalescent Plasma Therapy#268569HAL (France)
• Local Consolidative Radiation Therapy Plus TKI Versus TKI Alone in Driver Mutated OM-NSCLC#837579ClinicalTrials.gov
• Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma#249606ClinicalTrials.gov
• A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)#841484ClinicalTrials.gov
• A Study to Assess Safety of ImbruvicaTM in Indian Participants With Chronic Lymphocytic Leukemia or Mantle Cell Lymphoma Who Have Received at Least One Prior Therapy or Chronic Lymphocytic Leukemia With 17p Deletion#841881ClinicalTrials.gov
• Continuous Temperature Monitoring (CTM) for Cytokine Release Syndrome (CRS), an Immune-Related Adverse Event#857835ClinicalTrials.gov
• Real-world Study of First Line Pembrolizumab- or Nivolumab-treated HPV-positive Recurrent/Metastatic Oropharyngeal Squamous Cell Carcinoma#863188ClinicalTrials.gov
• Local Consolidative Therapy and Durvalumab for Oligoprogressive and Polyprogressive Stage III NSCLC After Chemoradiation and Anti-PD-L1 Therapy#346934ClinicalTrials.gov
• A Multicenter Real-World Study on TKI Therapy After Progression on First-Line TKI/IO Therapy or TKI/IO Therapy After Progression on First-Line TKI in Chinese Patients With Metastatic Renal Cell Carcinoma (mRCC)#838220ClinicalTrials.gov
• First Line Bio-immunotherapy With Thymosin Alpha 1 in Patients With Sensitizing EGFR Mutation Positive Non Small Cell Lung Cancer Who Are Taking Standard of Care Therapy#172301ClinicalTrials.gov
• Efficacy of Tedopi Plus Docetaxel or Tedopi Plus Nivolumab as Second-line Therapy in Metastatic Non-small-cell Lung Cancer Progressing After First-line Chemo-immunotherapy (Combi-TED)#230397ClinicalTrials.gov
• Bright Light Therapy in Patients With Melanoma or Non-small Cell Lung Cancer (NSCLC) Who Are Receiving First-Line Immune Checkpoint Blockade#346913ClinicalTrials.gov
• Phase I Trial of Atezolizumab and Interleukin-12 Gene Therapy in Metastatic Non-Small Cell Lung Cancer With Progression on First-Line Immunotherapy With or Without Chemotherapy#471444ClinicalTrials.gov
• Five-year outcomes of transoral robotic surgery with or without neoadjuvant chemotherapy in laryngeal squamous cell carcinoma: a preliminary experience#823177IRIS
• RC1012 Injection (Allo-DNT Cells) for the Prevention of Relapse in AML Patients After Allo-HSCT#842446ClinicalTrials.gov
• A Single-arm, Multicenter, Prospective Clinical Study of Adebrelimab Combined With Apatinib Neoadjuvant Therapy for Resectable Non-small Cell Lung Cancer#843744ClinicalTrials.gov
• Iressa Expanded Access Program (EAP)#848072ClinicalTrials.gov
• Neoadjuvant Durvalumab and Chemotherapy Followed by Surgery/CRT and Durvalumab in Borderline Resectable Stage III NSCLC#855577ClinicalTrials.gov
• Pembrolizumab After Radiation Therapy and Chemotherapy in Limited Stage Small Cell Lung Cancer#864391ClinicalTrials.gov
• Sintilimab Plus Anlotinib as Second or Further-line Therapy for ES-SCLC Who Have Progressed After Anti-PD-1/L1 Therapy#249605ClinicalTrials.gov
• Application of MRI Radiomics Features in Neoadjuvant Therapy of Head and Neck Squamous Cell Carcinoma#841955ClinicalTrials.gov
• Trial of Mosunetuzumab (BTCT4465A) as Consolidation Therapy in Participants With Diffuse Large B-Cell Lymphoma Following First-Line Immunochemotherapy and as Monotherapy or in Combination With Polatuzumab Vedotin in Elderly/Unfit Participants With Previously Untreated Diffuse Large B-Cell Lymphoma#148735ClinicalTrials.gov
• Nimotuzumab Combined With PD-1 Inhibitors and Chemotherapy in the Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma#307462ClinicalTrials.gov
• INfections in Patients Treated With CAR-T#839746ClinicalTrials.gov
• Safety Study of HLA-haplo Matched Allogenic Bone Marrow Derived Stem Cell Treatment in Amyotrophic Lateral Sclerosis#856673ClinicalTrials.gov
• PACIFIC: Primary Mediastinal Large B-cell Lymphoma Treated With Antibody Therapy, Checkpoint Inhibitor in Frontline With ImmunoChemotherapy#141010ClinicalTrials.gov
• T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)#860125ClinicalTrials.gov
• The use of injectable orthobiologics for knee osteoarthritis: A formal ESSKA‐ORBIT consensus. Part 2—Cell‐based therapy#11475HAL (France)
• Thailand's Emerging Role in the Cell and Gene Therapy Revolution: A Review of Progress and Potential.#13781NCBI PubMed Central
• Heterogeneous Sensitivity to Src Inhibitors in Oral Squamous Cell Carcinoma and Its Implications for Combination Therapy with Cisplatin#162263bioRxiv / medRxiv
• Anti-FLT3 CAR T-cell Therapy in FLT3 Positive Relapsed/Refractory Acute Myeloid Leukemia#172306ClinicalTrials.gov
• Treatment of Follicular Lymphoma With High Dose Therapy and Stem Cell Support Followed by Rituximab and Alpha Interferon#184841ClinicalTrials.gov
• Safety Study of Specific Tumor Target Drug Plus Immune System Therapy in Patients With Kidney Cancer#287524ClinicalTrials.gov
• Vaccine-expanded plasmablast-like B cells are associated with response to dendritic cell therapy in metastatic melanoma.#295254NCBI PubMed Central
• GPC3 Targeted CAR-T Cell Therapy in Advanced GPC3 Expressing Solid Tumor Malignancies#311118ClinicalTrials.gov
• Vaccine Therapy in Treating Patients With Multiple Myeloma#314388ClinicalTrials.gov
• Stem Cells and Secretomes for Infertility Therapy in Polycystic Ovary Syndrome (PCOS) Patients With Insulin Resistance.#321659ClinicalTrials.gov
• Patient Derived Organoids (PDOs) to Observe the Clinical Consistency of Personalized Neoadjuvant Therapy for Resectable Esophageal Squamous Cell Carcinoma#349941ClinicalTrials.gov